149 related articles for article (PubMed ID: 1931932)
1. Fluvoxamine: clinical trials and clinical use.
Freeman CP
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):19-25. PubMed ID: 1931932
[No Abstract] [Full Text] [Related]
2. Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.
Hrdina PD
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):10-8. PubMed ID: 1931931
[No Abstract] [Full Text] [Related]
3. The pharmacotherapy of depression.
Joffe RT
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):4-9. PubMed ID: 1931936
[No Abstract] [Full Text] [Related]
4. Serotonin selectivity for obsessive compulsive and panic disorders.
Montgomery SA; Bullock T; Fineberg N
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
[No Abstract] [Full Text] [Related]
5. Fluvoxamine: an antidepressant for the elderly?
Kellett JM
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):26-9. PubMed ID: 1931933
[No Abstract] [Full Text] [Related]
6. Introduction: advances in the pharmacotherapy of depression.
Lapierre YD
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):3. PubMed ID: 1931934
[No Abstract] [Full Text] [Related]
7. Fluvoxamine: a review of the controlled trials in depression.
Ware MR
J Clin Psychiatry; 1997; 58 Suppl 5():15-23. PubMed ID: 9184623
[TBL] [Abstract][Full Text] [Related]
8. Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
Schatzberg AF; Dessain E; O'Neil P; Katz DL; Cole JO
J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):44S-49S. PubMed ID: 3123528
[TBL] [Abstract][Full Text] [Related]
9. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
Nathan RS; Perel JM; Pollock BG; Kupfer DJ
J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
[TBL] [Abstract][Full Text] [Related]
10. New antidepressants and trends in the pharmacotherapy of depressive disorders.
Zarifian E; Rigal F
Psychiatr Clin North Am; 1983 Mar; 6(1):129-39. PubMed ID: 6889169
[No Abstract] [Full Text] [Related]
11. Is there action beyond receptors?
Hrdina PD
J Psychiatry Neurosci; 1993 Mar; 18(2):57-9. PubMed ID: 8384874
[No Abstract] [Full Text] [Related]
12. Fluvoxamine: an antidepressant with low (or no) epileptogenic effect.
Harmant J; van Rijckevorsel-Harmant K; de Barsy T; Hendrickx B
Lancet; 1990 Aug; 336(8711):386. PubMed ID: 1975375
[No Abstract] [Full Text] [Related]
13. Treatment of resistant depression with 5-HT uptake inhibitors.
Greden JF; Pande AC
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():442A-443A. PubMed ID: 1498908
[No Abstract] [Full Text] [Related]
14. [Open preliminary study of new antidepressive compound: citalopram].
Ropert R; Lôo H; Gay C
Encephale; 1984; 10(3):131-4. PubMed ID: 6594229
[TBL] [Abstract][Full Text] [Related]
15. [New horizons in drug therapy of depression].
Sirota P; Kaspi N
Harefuah; 1992 Jun; 122(11):712-6. PubMed ID: 1526564
[No Abstract] [Full Text] [Related]
16. Improving results with antidepressant drug therapy.
Sussman N; Cancro R
Compr Ther; 1990 Feb; 16(2):12-23. PubMed ID: 2311358
[No Abstract] [Full Text] [Related]
17. Pituitary-adrenocortical hyperfunction and intolerance to fluvoxamine, a selective serotonin uptake inhibitor.
Brown WA; Arato M; Shrivastava R
Am J Psychiatry; 1986 Jan; 143(1):88-90. PubMed ID: 3079969
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of depressive disorders].
Saiz Ruiz J; Ibáñez Cuadrado A
Rev Clin Esp; 1997 Nov; 197 Suppl 3():35-43. PubMed ID: 9477689
[No Abstract] [Full Text] [Related]
19. New antidepressants.
Kupecz D
Nurse Pract; 1995 Sep; 20(9):64-7. PubMed ID: 7501318
[No Abstract] [Full Text] [Related]
20. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy.
Mann JJ; Kapur S
Arch Gen Psychiatry; 1991 Nov; 48(11):1027-33. PubMed ID: 1747018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
